Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study

DSpace Repository

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study

Author: Valentini, Gabriele; Huscher, Doerte; Riccardi, Antonella; Fasano, Serena; Irace, Rosaria; Messiniti, Valentina; Matucci-Cerinic, Marco; Guiducci, Serena; Distler, Oliver; Maurer, Britta; Avouac, Jerome; Tarner, Ingo H.; Frerix, Marc; Riemekasten, Gabriela; Siegert, Elise; Czirjak, Laszlo; Lorand, Veronika; Denton, Christopher P.; Nihtyanova, Svetlana; Walker, Ulrich A.; Jaeger, Veronika K.; Del Galdo, Francesco; Abignano, Giuseppina; Ananieva, Lidia P.; Gherghe, Ana Maria; Mihai, Carina; Henes, Joerg Christoph; Schmeiser, Tim; Vacca, Alessandra; Moiseev, Sergey; Foeldvari, Ivan; Gabrielli, Armando; Krummel-Lorenz, Brigitte; Rednic, Simona; Allanore, Yannick; Mueeller-Ladner, Ulf
Tübinger Autor(en):
Henes, Jörg Christoph
Published in: Annals of The Rheumatic Diseases (2019), Bd. 78, H. 11, S. 1576-1582
Verlagsangabe: Bmj Publishing Group
Language: English
Full text: http://dx.doi.org/10.1136/annrheumdis-2019-215486
ISSN: 1468-2060
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)